Scientist in Biologics-Antibody generation
百济神州(北京)生物科技有限公司
- 公司规模:5000-10000人
- 公司性质:外资(欧美)
- 公司行业:制药/生物工程
职位信息
- 发布日期:2021-06-02
- 工作地点:北京
- 招聘人数:若干人
- 工作经验:无需经验
- 学历要求:招若干人
- 语言要求:不限
- 职位月薪:0.8-2.4万/月
- 职位类别:生物工程/生物制药
职位描述
Responsibilities:
职位责任:
Undertake the work of antibody discovery part of the company's biologics drug project, using hybridoma technology to prepare antibodies for various targets, including design of immunogens, mouse immunity, cell fusion, and antibody screening.
承担公司抗体药物项目的抗体发现部分的工作,利用杂交瘤技术制备针对各个靶点的抗体,包括免疫原的设计,小鼠的免疫,细胞融合以及抗体筛选等。
Screening hybridomas using a variety of methods such as ELISA, FACS and other high-throughput screening methods.
利用多种方法如ELISA,FACS和其他高通量筛选的方法对杂交瘤进行筛选。
Gene cloning and sequence analysis of hybridoma antibodies.
杂交瘤抗体的基因克隆及序列分析工作。
Develop hybridoma antibody discovery SOPs and continuously optimize the hybridoma antibody platform.
制定杂交瘤抗体发现的SOP,并对杂交瘤抗体平台进行持续的优化。
Collect and summarize experimental results.
收集整理并总结实验数据及结果。
职位要求:
Requirements:
任职要求:
M.S. degree in antibody technology, cell biology, molecular biology or B.S. molecular cloning, protein purification, or cell line establishment experience is required.
要求具有抗体技术、细胞生物学、分子生物学研究背景的理科硕士学历或具有相关分子克隆,蛋白纯化或者细胞系建立工作经验的理科学士学历。
Priority is given to those with extensive operational experience in hybridoma fusion.
优先考虑在杂交瘤融合方面有丰富操作经验者。
Familiar with different types of immunogens, such as protein immunity, cell immunity and DNA immunity.
擅长不同的免疫原形式的免疫,如蛋白免疫,细胞免疫及DNA免疫。
Have rich experience in antibody drug screening for ELISA, FACS or other high-throughput screening methods.
具有丰富的ELISA, FACS或其他高通量筛选的抗体药物筛选经验。
This position may work with collaborated groups.
该职位可能会其他组有项目合作。
Good literature skill in antibody technology and cancer drug discovery.
良好的抗体技术及抗肿瘤药物相关的文献查阅能力。
Strong sense of responsibility, communication skill and good team spirit.
具有强烈的责任感、良好的沟通能力和团队合作精神。
职位责任:
Undertake the work of antibody discovery part of the company's biologics drug project, using hybridoma technology to prepare antibodies for various targets, including design of immunogens, mouse immunity, cell fusion, and antibody screening.
承担公司抗体药物项目的抗体发现部分的工作,利用杂交瘤技术制备针对各个靶点的抗体,包括免疫原的设计,小鼠的免疫,细胞融合以及抗体筛选等。
Screening hybridomas using a variety of methods such as ELISA, FACS and other high-throughput screening methods.
利用多种方法如ELISA,FACS和其他高通量筛选的方法对杂交瘤进行筛选。
Gene cloning and sequence analysis of hybridoma antibodies.
杂交瘤抗体的基因克隆及序列分析工作。
Develop hybridoma antibody discovery SOPs and continuously optimize the hybridoma antibody platform.
制定杂交瘤抗体发现的SOP,并对杂交瘤抗体平台进行持续的优化。
Collect and summarize experimental results.
收集整理并总结实验数据及结果。
职位要求:
Requirements:
任职要求:
M.S. degree in antibody technology, cell biology, molecular biology or B.S. molecular cloning, protein purification, or cell line establishment experience is required.
要求具有抗体技术、细胞生物学、分子生物学研究背景的理科硕士学历或具有相关分子克隆,蛋白纯化或者细胞系建立工作经验的理科学士学历。
Priority is given to those with extensive operational experience in hybridoma fusion.
优先考虑在杂交瘤融合方面有丰富操作经验者。
Familiar with different types of immunogens, such as protein immunity, cell immunity and DNA immunity.
擅长不同的免疫原形式的免疫,如蛋白免疫,细胞免疫及DNA免疫。
Have rich experience in antibody drug screening for ELISA, FACS or other high-throughput screening methods.
具有丰富的ELISA, FACS或其他高通量筛选的抗体药物筛选经验。
This position may work with collaborated groups.
该职位可能会其他组有项目合作。
Good literature skill in antibody technology and cancer drug discovery.
良好的抗体技术及抗肿瘤药物相关的文献查阅能力。
Strong sense of responsibility, communication skill and good team spirit.
具有强烈的责任感、良好的沟通能力和团队合作精神。
职能类别:生物工程/生物制药
公司介绍
百济神州是一家立足于科学的全球性生物科技公司,专注于开发创新、可负担的药物,旨在为全球患者改善治疗效果,提高药物可及性。目前公司广泛的药物组合包括40多款临床候选药物。公司通过加强自主研发能力和合作,加速推进多元、创新的药物管线开发。我们致力于在2030年前为全球20多亿人全面改善药物可及性。百济神州在全球五大洲打造了一支超过8,000人的团队。
联系方式
- Email:shan.liu@beigene.com
- 公司地址:昌平区生命科学园 (邮编:102206)